A team of Lithuanian researchers has developed an innovative ultrasound device designed to improve blood circulation in the lower limbs and prevent severe complications like diabetic foot syndrome. Diabetic foot, characterized by ulcers, infections, and tissue necrosis, is a leading cause of hospitalizations and amputations. This advanced device uses low-frequency ultrasound waves to stimulate blood flow, enhance vascular tone, and reduce inflammation in tissues and nerves, offering a non-invasive and safe alternative to traditional treatments. By targeting microcirculatory disorders, the device addresses challenges not effectively managed by medications, making it a significant breakthrough for patients with diabetes and peripheral circulatory issues.
The technology utilizes piezoelectric elements to generate precise acoustic waves that penetrate tissues, activating the body’s vascular and neural systems to improve circulation throughout the leg. This innovative approach also helps regulate thrombogenesis, immune responses, and inflammatory processes, which are essential for maintaining vascular health. Designed for portability and safety, the device minimizes adverse effects with its non-contact, non-thermal operation.
Granted both Lithuanian and European patents, the device is expected to transform medical practices in rehabilitation hospitals, preventive medicine, and nursing care. It can also be customized for personal use, offering a convenient solution for older adults and individuals with chronic vascular dysfunction. Future applications may include integrating chemotherapeutic treatments with reduced systemic toxicity.
This ultrasound innovation marks a promising advancement in healthcare, combining portability, effectiveness, and safety to address critical medical needs, particularly for those affected by diabetes and circulatory disorders.
